Protagonist Therapeutics
Latest round
- Series C
Last raised
- Jul 2015
Total raised
- $41M
Investors
- 9
About Protagonist Therapeutics
Protagonist Therapeutics, Inc.Founded in 2001 and headquartered in Newark, US, Protagonist Therapeutics, Inc. specializes in peptide-based therapies. The company was co-founded by Aaron Rasmussen.Protagonist Therapeutics, Inc. specializes in peptide drug discovery and development, focusing on innovative therapies for rare and prevalent diseases with limited treatment options.
Who invested in Protagonist Therapeutics
9 investors across 3 rounds
See all investors in Protagonist Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Protagonist Therapeutics
Who invested in Protagonist Therapeutics?
Protagonist Therapeutics has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Protagonist Therapeutics raised?
Protagonist Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Protagonist Therapeutics last raise money?
Protagonist Therapeutics's most recent round on record is a Series C, in Jul 2015.
What does Protagonist Therapeutics do?
Protagonist Therapeutics is a biotechnology company.
Where is Protagonist Therapeutics headquartered?
Protagonist Therapeutics is headquartered in Newark, US.
Which VCs invest in companies like Protagonist Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Protagonist Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Protagonist Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.